Shanghai Raas Blood Products Company Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Raas Blood Products Company Limited with three other
companies in this sector in China:
China Biologic Products, Inc.
sales of 1.86 billion Chinese Renmimbi [US$276.66 million]
of which 100%
was Human Blood Product),
Tonghua Dongbao Medicines Company Limited
(1.67 billion Chinese Renmimbi [US$247.47 million]
of which 97%
was Pharmaceutical), and
Beijing Tiantan Biologic.
(1.62 billion Chinese Renmimbi [US$240.02 million]
During the year ended December of 2015, sales at
Shanghai Raas Blood Products Company Limited were 2.01 billion Chinese Renmimbi (US$298.80 million).
increase of 52.6%
versus 2014, when the company's sales were 1.32 billion Chinese Renmimbi.
Sales of Traditional Chinese Medicine and Food saw an increase
60.5% in 2015, from
35.59 million Chinese Renmimbi to 57.13 million Chinese Renmimbi.
Not all segments of Shanghai Raas Blood Products Company Limited experienced an increase in sales in 2015:
sales of Other Operating fell 21.1% to 2.09 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).